Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral: Vanier Canada Graduate Scholarships

University of Toronto

$150,000.00

Assessing the value of genetic counselling and translation of emerging genetic discoveries for schizophrenia

FY 2010-11

Summary
Schizophrenia is a serious mental illness that affects about 1 in 100 Canadians in their lifetime. The disease is often called "youth's greatest disabler." The illness has a significant burden on those afflicted, their families, and society in general. Schizophrenia is a disorder with a large genetic component that is yet to be completely understood. Genetic counselling is a communication process that deals with the concerns associated with the occurrence, or risk of occurrence, of a genetic disorder in a family. Increasing public awareness of genetic risk for disease and the advent of personalized medicine makes it likely that those with a family history of schizophrenia will more often desire genetic counselling in the future. The purpose of this study is to assess for the first time the value of genetic counselling for schizophrenia. Results of this novel study will help us understand how people make sense of their own risk for developing schizophrenia. We will discover how genetic counselling may be helpful in addressing concerns and misconceptions about the illness and how it may or may not run in families. In addition, the results promise to provide much needed strategies to improve the procedure, availability, and uptake of genetic counselling in mental healthcare. Through the pioneering study of 22q11.2 Deletion Syndrome and other emerging genomic disorders, we will examine the importance of having a specific, identifiable genetic cause for schizophrenia. Our goal is to actively translate genetic discoveries into valuable services for Canadians with serious mental illness and their families.
Program
Doctoral: Vanier Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
218043
Name
Costain Gregory
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Assessing the value of genetic counselling and translation of emerging genetic discoveries for schizophrenia
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
22q11.2 Deletion Syndrome; Clinical Genetics; Complex Disease; Copy Number Variation; Digeorge Syndrome; Emerging Genomic Disorders; Genetic Counselling; Knowledge Translation; Schizophrenia; Serious Mental Illness
Abstract
Schizophrenia is a serious mental illness that affects about 1 in 100 Canadians in their lifetime. The disease is often called "youth's greatest disabler." The illness has a significant burden on those afflicted, their families, and society in general. Schizophrenia is a disorder with a large genetic component that is yet to be completely understood. Genetic counselling is a communication process that deals with the concerns associated with the occurrence, or risk of occurrence, of a genetic disorder in a family. Increasing public awareness of genetic risk for disease and the advent of personalized medicine makes it likely that those with a family history of schizophrenia will more often desire genetic counselling in the future. The purpose of this study is to assess for the first time the value of genetic counselling for schizophrenia. Results of this novel study will help us understand how people make sense of their own risk for developing schizophrenia. We will discover how genetic counselling may be helpful in addressing concerns and misconceptions about the illness and how it may or may not run in families. In addition, the results promise to provide much needed strategies to improve the procedure, availability, and uptake of genetic counselling in mental healthcare. Through the pioneering study of 22q11.2 Deletion Syndrome and other emerging genomic disorders, we will examine the importance of having a specific, identifiable genetic cause for schizophrenia. Our goal is to actively translate genetic discoveries into valuable services for Canadians with serious mental illness and their families.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Costain, Gregory
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
University of Toronto - $150,000 Grant (2010-11) | Canada Spends